Drugs / Sodium Sivelestat
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07196605 | Oct 2025 → Mar 2026 | cerebral artery occlusion, ischemic stroke | Xuanwu Hospital, Beijing | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sodium Sivelestat | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07196605 ↗ |
| Action | Inhibit | “Sodium sivelestat, a selective NE inhibitor” NCT07196605 ↗ |
| Route | Intravenous | “administer intravenous sodium sivelestat” NCT07196605 ↗ |